Article

ATM Inhibition Synergizes with Fenofibrate in High Grade Serous Ovarian Cancer Cells

2020-05-30

Abstract excerpt

<h4>Background</h4> Epithelial ovarian cancer (EOC) is the deadliest gynecological malignancy in the United States with high grade serous ovarian cancer (HGSOC) as the most commonly diagnosed subtype. While therapies targeting deficiencies in the homologous recombination (HR) pathway are emerging as the standard treatment for HGSOC patients, this strategy is limited to the 50% of patients with a deficiency in thi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3003a619-92e8-50aa-a77f-8750f2c81b69
DOI: 10.1101/2020.05.29.123919

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ATM Inhibition Synergizes with Fenofibrate in High Grade Serous Ovarian Cancer CellsDOI 10.1101/2020.05.29.123919Read

Advances in ATM, ATR, WEE1, and CHK1/2 inhibitors in the treatment of PARP inhibitor-resistant ovarian cancerSemantic proximity Read

Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinomaSemantic proximity Read

Dysregulated Cholesterol Metabolism with Anomalous PI3K/Akt/mTOR pathway Predicts Poor Carboplatin Response in High Grade Serous Ovarian CancerSemantic proximity Read

Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repairSemantic proximity Read

ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian CancerSemantic proximity Read

The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancerSemantic proximity Read

Characterization of DNA damage repair pathway utilization in high-grade serous ovarian cancers yields rational therapeutic approachesSemantic proximity Read

Hormone Receptor Expression and Disease Prognosis in High-Grade Serous Ovarian CancerSemantic proximity Read

ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancersSemantic proximity Read

Folate receptor alpha protein expression in ovarian serous cystadenocarcinoma tumors of The Cancer Genome Atlas: exploration beyond single-agent therapySemantic proximity Read

ACSM3 suppresses the pathogenesis of high-grade serous ovarian carcinoma via promoting AMPK activitySemantic proximity Read

Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma.Semantic proximity Read